Advances in prostate cancer screening are giving doctors more ways to assess cancer risk and determine when further testing may be needed. Johns Hopkins urologist Christian Pavlovich, M.D., explains how newer blood and urine tests, along with imaging advances, can help guide screening and biopsy decisions.
